Commonwealth Equity Services LLC increased its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) by 23.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,409 shares of the medical research company’s stock after acquiring an additional 5,881 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Agilent Technologies were worth $3,817,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its holdings in shares of Agilent Technologies by 34.8% during the third quarter. EverSource Wealth Advisors LLC now owns 298 shares of the medical research company’s stock worth $37,000 after acquiring an additional 77 shares during the period. Edge Capital Group LLC grew its holdings in Agilent Technologies by 53.0% in the 3rd quarter. Edge Capital Group LLC now owns 303 shares of the medical research company’s stock valued at $37,000 after buying an additional 105 shares in the last quarter. Guardian Wealth Advisors LLC bought a new position in Agilent Technologies during the 3rd quarter worth $42,000. Penserra Capital Management LLC acquired a new stake in shares of Agilent Technologies during the first quarter worth $60,000. Finally, Avondale Wealth Management bought a new stake in shares of Agilent Technologies in the third quarter valued at about $61,000.
Agilent Technologies Stock Performance
Agilent Technologies stock opened at $140.90 on Thursday. The stock has a market cap of $41.66 billion, a PE ratio of 31.81, a P/E/G ratio of 2.10 and a beta of 1.04. The company has a quick ratio of 1.53, a current ratio of 2.11 and a debt-to-equity ratio of 0.49. Agilent Technologies, Inc. has a 12-month low of $112.52 and a 12-month high of $160.26. The business’s 50-day moving average price is $150.50 and its two-hundred day moving average price is $142.71.
Agilent Technologies announced that its board has approved a stock repurchase program on Monday, January 9th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the medical research company to repurchase up to 4.4% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s board of directors believes its stock is undervalued.
Agilent Technologies Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 26th. Investors of record on Tuesday, April 4th will be issued a $0.225 dividend. The ex-dividend date is Monday, April 3rd. This represents a $0.90 dividend on an annualized basis and a yield of 0.64%. Agilent Technologies’s payout ratio is 20.32%.
Insider Buying and Selling
In related news, SVP Henrik Ancher-Jensen sold 29,500 shares of the company’s stock in a transaction that occurred on Wednesday, December 14th. The stock was sold at an average price of $155.78, for a total value of $4,595,510.00. Following the sale, the senior vice president now directly owns 70,793 shares in the company, valued at $11,028,133.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, VP Padraig Mcdonnell sold 672 shares of Agilent Technologies stock in a transaction dated Tuesday, December 13th. The stock was sold at an average price of $160.00, for a total value of $107,520.00. Following the completion of the transaction, the vice president now directly owns 15,529 shares of the company’s stock, valued at approximately $2,484,640. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Henrik Ancher-Jensen sold 29,500 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, December 14th. The stock was sold at an average price of $155.78, for a total value of $4,595,510.00. Following the completion of the sale, the senior vice president now owns 70,793 shares of the company’s stock, valued at $11,028,133.54. The disclosure for this sale can be found here.
Analyst Ratings Changes
A has been the subject of several analyst reports. UBS Group lifted their price objective on shares of Agilent Technologies from $152.00 to $170.00 and gave the stock a “buy” rating in a research note on Tuesday, December 20th. Jefferies Financial Group increased their price target on Agilent Technologies from $158.00 to $168.00 in a research report on Tuesday, November 22nd. SVB Leerink lifted their price objective on Agilent Technologies from $160.00 to $170.00 and gave the company an “outperform” rating in a report on Friday, January 6th. KeyCorp upped their target price on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research report on Tuesday, November 22nd. Finally, Cowen raised their price target on Agilent Technologies from $160.00 to $168.00 in a research report on Tuesday, November 22nd. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $163.31.
About Agilent Technologies
Agilent Technologies, Inc engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.
Featured Articles
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Are Korn Ferry’s Results a Canary in the Employment Coal Mine?
- META Platforms May See its Biggest Opening Yet for New Highs
- Penny Stock Vinco Ventures Could Be Big Winner
- Is Chip Design Specialist Synopsys A Gem Hiding In Plain Sight?
- Should You Park Some Capital with Casey’s General Stores?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
